World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 75 2003 1835 981 887 314 17433

Elizabeth A. Repasky publications per year

The chart shows the history of publications by Elizabeth A. Repasky between 1981 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Elizabeth A. Repasky published across 45 years, from 1981 to 2025, averaging 9.3 papers a year. Output peaked at 89 publications in 2023. 22 of the 419 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1981 to 2025. Vertical axis: number of publications, 0 to 89. Peak 89 publications in 2023. 1981: 1 publication 1982: 2 publications 1983: 0 publications 1984: 2 publications 1985: 3 publications 1986: 3 publications 1987: 7 publications 1988: 3 publications 1989: 3 publications 1990: 1 publication 1991: 1 publication 1992: 3 publications 1993: 2 publications 1994: 2 publications 1995: 1 publication 1996: 5 publications 1997: 4 publications 1998: 3 publications 1999: 9 publications 2000: 10 publications 2001: 7 publications 2002: 10 publications 2003: 5 publications 2004: 6 publications 2005: 9 publications 2006: 10 publications 2007: 9 publications 2008: 13 publications 2009: 7 publications 2010: 11 publications 2011: 13 publications 2012: 12 publications 2013: 14 publications 2014: 10 publications 2015: 18 publications 2016: 10 publications 2017: 6 publications 2018: 8 publications 2019: 13 publications 2020: 20 publications 2021: 19 publications 2022: 13 publications 2023: 89 publications 2024: 13 publications 2025: 9 publications
1981 2025

419 publications in total across all disciplines

View publications per year as a table
Elizabeth A. Repasky: publications per year, 1981 to 2025
Year Publications
1981 1
1982 2
1983 0
1984 2
1985 3
1986 3
1987 7
1988 3
1989 3
1990 1
1991 1
1992 3
1993 2
1994 2
1995 1
1996 5
1997 4
1998 3
1999 9
2000 10
2001 7
2002 10
2003 5
2004 6
2005 9
2006 10
2007 9
2008 13
2009 7
2010 11
2011 13
2012 12
2013 14
2014 10
2015 18
2016 10
2017 6
2018 8
2019 13
2020 20
2021 19
2022 13
2023 89
2024 13
2025 9
Total 419
Download as CSV

Elizabeth A. Repasky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elizabeth A. Repasky sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 312–321 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97 314
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Elizabeth A. Repasky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth A. Repasky sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 74–75 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133 75
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Elizabeth A. Repasky is a researcher affiliated with Roswell Park Cancer Institute in the United States. Their work primarily spans the field of Medicine, with a focus on Oncology, Immunology, Psychiatry and Mental Health, Molecular Biology, and Physiology.

The scholar's research covers a range of topics related to cancer biology and immune response, concentrating on:

  • Cancer, Stress, Anesthesia, and Immune Response
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Head and Neck Cancer Studies
  • Cancer, Hypoxia, and Metabolism

Frequently published venues for their work include:

  • Cancers
  • Cancer Research
  • Journal of Clinical Oncology
  • The Journal of Immunology
  • Oral Oncology

Some of Elizabeth A. Repasky's notable publications are:

  • Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity (2020, Clinical Cancer Research)
  • Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment (2021, Cancer Immunology Research)
  • β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME (2021, Cell Reports)
  • Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation (2020, Nature Communications)
  • Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies (2020, Seminars in Immunopathology)

Frequent collaborators in the scholar's research include:

  • Hemn Mohammadpour
  • Anurag K. Singh
  • Shipra Gandhi
  • Kristopher Attwood
  • Cameron R. MacDonald

Best Publications

  • Fever and the thermal regulation of immunity: the immune system feels the heat

    Sharon S Evans;Elizabeth A Repasky;Daniel T Fisher

  • Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin

    Sandra S. McAllister;Ann M. Gifford;Ashley L. Greiner;Ashley L. Greiner;Stephen P. Kelleher;Stephen P. Kelleher

  • Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature

    Kathleen M. Kokolus;Maegan L. Capitano;Chen-Ting Lee;Jason W.-L. Eng

  • Temperature Matters! And Why It Should Matter to Tumor Immunologists

    Elizabeth A. Repasky;Sharon S. Evans;Mark W. Dewhirst

  • Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.

    Francisco J Hernandez-Ilizaliturri;Venkata Jupudy;Julie Ostberg;Ezogelin Oflazoglu

  • β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells

    Hemn Mohammadpour;Cameron R. MacDonald;Guanxi Qiao;Minhui Chen

  • Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity

    Xiang-Yang Wang;Latif Kazim;Elizabeth A. Repasky;John R. Subjeck

  • IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

    Daniel T. Fisher;Qing Chen;Joseph J. Skitzki;Jason B. Muhitch

  • β-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy

    Mark J. Bucsek;Guanxi Qiao;Cameron R. MacDonald;Thejaswini Giridharan

  • Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.

    Takuji Naka;Kenji Sugamura;Bonnie L Hylander;Michael B Widmer

  • Hyperthermia as an immunotherapy strategy for cancer

    Joseph J Skitzki;Elizabeth A Repasky;Sharon S Evans

  • Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia

    Randy Burd;Thomas S. Dziedzic;Yan Xu;Michael A. Caligiuri

  • A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response

    Jason W.-L. Eng;Kathleen M. Kokolus;Chelsey B. Reed;Bonnie L. Hylander

  • Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis.

    Tongtong Wang;Deborah Hopkins;Cheryl Schmidt;Sandra Silva

  • Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker

    Ezogelin Oflazoglu;Ivan J. Stone;Kristine Gordon;Christopher G. Wood

  • Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.

    Kathleen M Kokolus;Ying Zhang;Jeffrey M Sivik;Carla Schmeck

  • β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress.

    Guanxi Qiao;Mark J. Bucsek;Nicolette M. Winder;Nicolette M. Winder;Minhui Chen

  • Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells

    Julie R. Ostberg;Baris E. Dayanc;Min Yuan;Ezogelin Oflazoglu

  • Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response

    Guanxi Qiao;Minhui Chen;Mark J. Bucsek;Elizabeth A. Repasky

  • Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation

    Jason W.-L. Eng;Chelsey B. Reed;Kathleen M. Kokolus;Rosemarie Pitoniak

  • Heat shock proteins as vaccine adjuvants in infections and cancer

    Brahm H. Segal;Xiang-Yang Wang;Carly G. Dennis;Richard Youn

  • Fever-Range Hyperthermia Enhances L-Selectin-Dependent Adhesion of Lymphocytes to Vascular Endothelium

    Wan-Chao Wang;Lorin M. Goldman;David M. Schleider;Michelle M. Appenheimer

  • Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules.

    Sharon S. Evans;Wan Chao Wang;Mark D. Bain;Randy Burd

Frequent Co-Authors

John R. Subjeck
John R. Subjeck Roswell Park Cancer Institute
Richard B. Bankert
Richard B. Bankert University at Buffalo, State University of New York
Kelvin P. Lee
Kelvin P. Lee Roswell Park Comprehensive Cancer Center
Alex A. Adjei
Alex A. Adjei Cleveland Clinic
Christine B. Ambrosone
Christine B. Ambrosone Roswell Park Cancer Institute
Scott I. Abrams
Scott I. Abrams Roswell Park Cancer Institute
Steven G. Reed
Steven G. Reed Infectious Disease Research Institute
George Chen
George Chen University of Southampton
Stephen B. Edge
Stephen B. Edge Roswell Park Cancer Institute
Paul K. Wallace
Paul K. Wallace Roswell Park Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA can open doors to diverse healthcare roles, particularly in nursing and advanced practice. Many professionals consider transitioning to specialized fields such as acute care, which requires targeted skills and knowledge. For those interested, exploring acute care nurse practitioner programs provides valuable insights into this advanced practice path.

Accelerated pathways are popular among students aiming for rapid career advancement. Online options like accelerated RN to NP programs offer flexibility and a fast-track route to becoming a nurse practitioner. These programs are ideal for registered nurses ready to expand their scope of practice.

For those without a nursing background, 12-month intensive courses serve as a gateway into the nursing profession. The 12-month accelerated nursing programs online for non nurses provide an efficient start, focusing on the essential skills needed to enter the field quickly.

Additionally, students seeking easier admission routes might consider programs highlighted in the easiest ABSN programs to get into guide. These accelerated BSN programs balance accessibility with comprehensive nursing training, setting a solid foundation for careers in health sciences and immunology-related fields.

Best Scientists Citing Elizabeth A. Repasky

Trending Scientists

Recently Published Articles